EX-99.1 2 drr0192_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana, India.

CIN : L85195TG1984PLC004507

 

Tel    :+91 40 4900 2900

Fax   :+91 40 4900 2999

Email :mail@drreddys.com

www.drreddys.com

 
 
 
 
 

 

February 14, 2020

 

Corporate Relationship Department

National Stock Exchange of India Ltd.

BSE Limited

“Exchange Plaza”

Dalal Street, Fort

Bandra-Kurla Complex, Bandra (East),

Mumbai – 400 001

Mumbai – 400 051

Fax Nos.: 022-22723121 / 22723719 /

Fax Nos.: 022-26598120/ 26598237/

                 22722037 / 22722039

                 26598238

 

 

Scrip Code: 500124

Scrip Code: DRREDDY-EQ

 
 
 
 
 

 

Dear Sirs,

Sub: Intimation

 

This is to inform you that the audit of our Formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the US FDA, has been completed today with zero observation.

 

This is for your information.

 

With regards,

 

/s/ Vikas Sabharwal

 

Vikas Sabharwal

 

Assistant Company Secretary

 

 
 
 
 
 

 

CC:- New York Stock Exchange Inc.(Stock Code :RDY)